MarketPulse

securities fraud investigation

41 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

MVST Stock Plunges 34% After Disastrous Earnings; Law Firm Launches Fraud Investigation

Microvast ($MVST) plunged 34% after reporting $96.5M revenue (29% below consensus) and 1% gross margins, triggering securities fraud investigation by Pomerantz LLP.
MVSTMVSTWclass action lawsuitearnings miss
BenzingaBenzinga··Schall Law Firm

Microvast Faces Securities Probe After 34% Stock Plunge on Margin Collapse

Schall Law Firm investigates $MVST for alleged securities violations following Q4 results showing 15% revenue decline and gross margin contraction.
MVSTMVSTWstock declineshareholder litigation
BenzingaBenzinga··Schall Law Firm

Nuvation Bio Stock Plummets 25% as Fraud Probe Launches Over IBTROZI Disclosure

Schall Law Firm investigates $NUVB for potential securities violations after revealing 75% treatment discontinuations in oncology therapy, triggering sharp stock decline.
NUVBstock declinemisleading statements
BenzingaBenzinga··Schall Law Firm

DSGR Faces Securities Fraud Investigation Over Conflicting Tariff Claims

Schall Law Firm investigates DSGR over conflicting tariff statements; stock fell 26.3% after Q4 2025 earnings.
DSGRstock declineshareholder litigation
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Stellantis Faces Securities Investigation After €22.2B Charge Triggers 23.7% Crash

Law firm investigates $STLA for potential securities violations following €22.2B charge announcement that crashed stock 23.7% in single day.
STLAshareholder lawsuitstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Kessler Topaz Meltzer & Check, Llp

GoDaddy Stock Plunges 14% as Securities Investigation Looms Over Weak Guidance

Law firm investigates $GDDY after Q4 earnings miss. Stock fell 14% on disappointing bookings, .com domain pricing pressure, and cautious 2026 outlook.
GDDYclass action lawsuitinvestor losses
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

Oddity Tech Plunges 49% as Ad Algorithm Changes Trigger $14.74 Stock Collapse

Oddity Tech shares crashed 49% after disclosing algorithm changes from its largest ad partner will trigger 30% Q1 revenue decline, prompting securities fraud investigation.
ODDfinancial resultssecurities fraud investigation
BenzingaBenzinga··Law Offices Of Howard G. Smith

Alight Stock Plunge Sparks Securities Fraud Probe Over Missed Guidance

Law Offices of Howard G. Smith investigates $ALIT after shareholder losses tied to missed revenue targets and downward guidance revisions in August 2025 and February 2026.
ALITinvestor lossesstock price decline
BenzingaBenzinga··Law Offices Of Frank R. Cruz

Alight Faces Securities Fraud Probe After Consecutive Revenue Misses and Dividend Cut

Securities fraud investigation launched against $ALIT following 18.3% and 38.2% stock declines tied to missed revenue guidance and earnings shortfalls in 2025-2026.
ALITstock declinesecurities fraud investigation
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

Tennant Stock Plummets 23% After Massive EPS Miss; Securities Probe Deepens

Tennant Company's $TNC stock crashed after reporting 2025 EPS of $0.48, missing estimates by $1.22, amid ERP implementation failures. Securities fraud investigation ongoing.
TNCrevenue missearnings miss
BenzingaBenzinga··Frank R. Cruz Law Offices

Tennant Company Under Securities Fraud Probe After Massive Earnings Miss

Legal investigation launched into $TNC after company reported EPS of $0.48 versus $1.70 estimate, citing ERP implementation failures.
TNCrevenue missearnings miss
BenzingaBenzinga··Law Offices Of Howard G. Smith

Tennant Company Stock Plunges 23% on Missed Earnings; Securities Fraud Investigation Launched

Tennant Company ($TNC) faces securities investigation after 23.4% stock decline following massive 2025 earnings miss tied to ERP system implementation failures.
TNCearnings missstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Lifecore Biomedical Shareholders Face Steep Losses as Law Firm Launches Securities Investigation

Johnson Fistel investigates Lifecore Biomedical over 15-18% revenue miss and 18% stock decline, offering shareholder recovery options for alleged securities law violations.
HRZNHTFCGIIILFCRinvestor lossesshareholder rights
BenzingaBenzinga··Business Wire

Nektar Therapeutics Faces Securities Fraud Investigation After Failed Trial Announcement

Law firm investigates $NKTR over December trial failure disclosure. Stock dropped 7.8% after alopecia areata Phase 2b study missed endpoints due to ineligible patients.
NKTRshareholder lawsuitstock price decline
BenzingaBenzinga··Business Wire

DSGR Faces Securities Fraud Probe After 26% Stock Plunge on Earnings Miss

Distribution Solutions Group faces securities fraud probe after March earnings miss triggered 26.3% stock plunge to $21.90, amid end-market softness and cost pressures.
DSGRstock declinefinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Netskope Faces Legal Scrutiny Over Ballooning Operating Losses Despite Revenue Growth

Law firm Johnson Fistel investigates Netskope's $652.6M operating loss in FY2026, more than double prior year, amid revenue expansion.
NTSKinvestor lossesshareholder rights
BenzingaBenzinga··Business Wire

Grocery Outlet Stock Plummets 28% on Store Closure Announcement; Fraud Investigation Launched

Grocery Outlet ($GO) stock plunged 27.9% after announcing 36 store closures due to overexpansion, triggering a securities fraud investigation and shareholder litigation.
GOstock declineclass action
BenzingaBenzinga··Business Wire

Via Transportation Under Securities Fraud Investigation Over Alleged Business Model Misrepresentation

Law firm investigates $VIA for securities violations after stock plummets 59.7% from IPO price. Bleeker Street Research alleges misrepresentation of business model and ARR inflation.
VIAstock declineIPO
BenzingaBenzinga··Business Wire

DSGR Stock Plunges 26% as Securities Fraud Probe Launched Over Earnings Miss

Law firm investigates $DSGR for potential securities fraud following March earnings miss that triggered 26.3% stock decline to $21.90.
DSGRstock declinefinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Corcept Stock Plummets 50% After FDA Rejects Key Drug; Lawsuit Probe Launched

Johnson Fistel investigates Corcept Therapeutics ($COPT) for securities violations after FDA rejected relacorilant application, triggering 50% stock decline.
CORTinvestor lossesrelacorilant